Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Exclusion Criteria

• •Seizures occurring in clusters.
• •Status epilepticus within 6 months of Visit 1
• •History of non-epileptic seizures
• •Subjects on vigabatrin
• •Subjects on felbamate, unless treatment has been continuous for \>2 years
• •Ongoing psychiatric disease other than mild controlled disorders.
• •Subjects with clinically significant organ dysfunction
• •Known allergic reaction or intolerance to pyrrolidine derivatives and/or excipients
• •Pregnant or lactating women
• •Subjects currently taking levetiracetam (LEV)
• •Use of benzodiazepines (for any indication) taken at a higher frequency than an average of once a week, unless counted as one of the concomitant Antiepileptic Drug (AEDs)